4.25
Arbutus Biopharma Corp Aktie (ABUS) Neueste Nachrichten
Analyzing drawdowns of Arbutus Biopharma Corporation with statistical tools2025 Technical Patterns & Expert Approved Momentum Ideas - newser.com
What machine learning models say about Arbutus Biopharma Corporation2025 Key Lessons & AI Based Buy/Sell Signal Reports - newser.com
Building trade automation scripts for Arbutus Biopharma CorporationTake Profit & Weekly Breakout Watchlists - newser.com
Arbutus Biopharma Corporation stock volume spike explainedQuarterly Risk Review & High Win Rate Trade Alerts - newser.com
Is Arbutus Biopharma Corporation stock bottoming outLong Setup & Weekly Setup with ROI Potential - newser.com
what machine learning models say about arbutus biopharma corporationJuly 2025 PreEarnings & Risk Controlled Daily Plans - newser.com
Is Arbutus Biopharma Corporation reversing from oversold territoryOptions Play & Weekly Return Optimization Plans - newser.com
Using economic indicators to assess Arbutus Biopharma Corporation potential2025 Market WrapUp & Stepwise Trade Signal Guides - newser.com
Aug Setups: Whats next for Arbutus Biopharma Corporation stockLong Setup & Weekly Breakout Watchlists - khodrobank.com
Reversal indicators forming on Arbutus Biopharma Corporation stockQuarterly Growth Report & Fast Entry Momentum Trade Alerts - newser.com
What MACD signals say about Arbutus Biopharma CorporationAnalyst Upgrade & Technical Pattern Based Signals - newser.com
Arbutus Biopharma Corporation $ABUS Shares Purchased by Goldman Sachs Group Inc. - MarketBeat
Aug Rallies: Is Arbutus Biopharma Corporation stock a top performer YTD2025 Price Action Summary & Technical Pattern Based Signals - خودرو بانک
RSI Check: Should I set a stop loss on RELYMarket Performance Report & Free Community Consensus Stock Picks - خودرو بانک
Arbutus: IP Drama With High Stakes (NASDAQ:ABUS) - Seeking Alpha
Fundamentals Check: What’s next for Arbutus Biopharma Corporation stockWeekly Volume Report & Risk Controlled Daily Trade Plans - khodrobank.com
Has Arbutus Biopharma Corporation formed a bullish divergenceCEO Change & Weekly Market Pulse Updates - newser.com
Published on: 2025-09-15 00:38:22 - newser.com
is arbutus biopharma corporation reversing from oversold territory2025 Short Interest & Daily Risk Controlled Trade Plans - newser.com
Arbutus Biopharma (NASDAQ:ABUS) Stock Price Down 4.6%What's Next? - MarketBeat
Arbutus Biopharma Corporation stock retracement – recovery analysisQuarterly Growth Report & Expert Approved Momentum Ideas - newser.com
Arbutus Biopharma (NASDAQ:ABUS) Trading Up 6.4%Still a Buy? - MarketBeat
Is Arbutus Biopharma Corporation showing signs of accumulationQuarterly Portfolio Report & Expert Approved Momentum Ideas - Newser
Adage Capital Partners GP L.L.C. Cuts Stake in Arbutus Biopharma Corporation $ABUS - MarketBeat
What to expect from Arbutus Biopharma Corporation in the next 30 daysQuarterly Trade Summary & Daily Entry Point Alerts - Newser
Arbutus Biopharma (NASDAQ:ABUS) Hits New 1-Year HighStill a Buy? - MarketBeat
Relative strength of Arbutus Biopharma Corporation in sector analysisTrade Entry Report & Long-Term Investment Growth Plans - Newser
Combining price and volume data for Arbutus Biopharma CorporationDollar Strength & Reliable Intraday Trade Alerts - Newser
How institutional ownership impacts Arbutus Biopharma Corporation stockPortfolio Performance Summary & Weekly Market Pulse Alerts - Newser
Key resistance and support levels for Arbutus Biopharma CorporationJuly 2025 Selloffs & Short-Term High Return Ideas - Newser
Invesco Ltd. Has $487,000 Stock Holdings in Arbutus Biopharma Corporation $ABUS - MarketBeat
Two Seas Capital LP Acquires 725,000 Shares of Arbutus Biopharma Corporation $ABUS - MarketBeat
Chart based analysis of Arbutus Biopharma Corporation trendsWeekly Trend Summary & AI Powered Market Trend Analysis - Newser
Combining machine learning predictions for Arbutus Biopharma CorporationMarket Growth Review & AI Driven Price Forecasts - Newser
Is Arbutus Biopharma Corporation forming a bottoming baseWeekly Profit Report & Long-Term Capital Growth Ideas - Newser
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):